Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: incomep who wrote (6843)	4/11/1998 2:24:00 AM
From: VLAD	Respond to of 23519

<<why are there so many anti-MUSE doctors?>> How many do you know of? I only know of one - - that Casey guy who runs that impotence thread. VLAD

To: incomep who wrote (6843)	4/11/1998 8:19:00 AM
From: Bradpalm1	Read Replies (2) \| Respond to of 23519

Great concept---fair product---terrible company IMO, there are much better places to put your money in this unbelievable market. Muse was the ED darling last year but this year it's Viagra. You can't fight market or public sentiment. Viagra will be everything the trials have said and more. I've covered my short position since this stock dipped to single digits but still think the short-term looks bleak for the company (even with FDA approval). Long-term prospects depend on whether Vivus is able to evolve their concept to the next level (Muse II or another improved transurethral product). Fighting those lawsuits will also take its toll on the company. Management is the ultimate key to the success of any company (look at HVSF and ZONA). Unfortunately, Leland hasn't shown himself to be able effectively market his product or deal honestly with the "street". Until these things happen, Vivus remains dead money in this marketplace. Bradpalm1